Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $390.49 | 25 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $104.70 | 7 | $0 (2019) |
| PFIZER INC. | $95.19 | 7 | $0 (2019) |
| The Medicines Company | $47.78 | 2 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $36.24 | 2 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $32.33 | 2 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $28.29 | 2 | $0 (2017) |
| Sunovion Pharmaceuticals Inc. | $18.55 | 1 | $0 (2017) |
| Otsuka America Pharmaceutical, Inc. | $16.09 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $11.32 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $17.50 | 1 | Janssen Pharmaceuticals, Inc ($17.50) |
| 2019 | $41.10 | 3 | PFIZER INC. ($26.75) |
| 2018 | $29.12 | 2 | Allergan Inc. ($15.81) |
| 2017 | $302.77 | 19 | Allergan Inc. ($74.54) |
All Payment Transactions
25 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/16/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/17/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/04/2019 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/05/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 10/21/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 06/14/2018 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/20/2017 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: NEPHROLOGY | ||||||
| 07/06/2017 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/27/2017 | Sunovion Pharmaceuticals Inc. | BROVANA (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: RESPIRATORY | ||||||
| 06/06/2017 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/11/2017 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/27/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/13/2017 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $11.74 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/12/2017 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/28/2017 | Merck Sharp & Dohme Corporation | DIFICID (Drug) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/16/2017 | Merck Sharp & Dohme Corporation | DIFICID (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/15/2017 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/14/2017 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 03/08/2017 | The Medicines Company | ORBACTIV (Drug) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/28/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.10 | General |
| Category: Cardiovascular | ||||||
| 01/26/2017 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/24/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.19 | General |
| Category: Cardiovascular | ||||||
| 01/18/2017 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $11.32 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/17/2017 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/04/2017 | The Medicines Company | MINOCIN IV (Drug), ORBACTIV | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: INFECTIOUS DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 253 | 1,002 | $239,076 | $88,801 |
| 2022 | 8 | 470 | 1,114 | $287,572 | $80,009 |
| 2021 | 9 | 696 | 1,149 | $348,846 | $77,938 |
| 2020 | 10 | 673 | 1,052 | $348,792 | $79,492 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 71 | 442 | $113,101 | $46,806 | 41.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 94 | 470 | $96,060 | $31,529 | 32.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 44 | 46 | $21,371 | $6,564 | 30.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 28 | 28 | $6,048 | $2,798 | 46.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 16 | 16 | $2,496 | $1,105 | 44.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 153 | 518 | $124,020 | $30,945 | 25.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 38 | 281 | $56,490 | $25,633 | 45.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 108 | 108 | $42,123 | $9,245 | 21.9% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 42 | 42 | $21,168 | $4,335 | 20.5% |
| 99225 | Follow-up observation care per day, typically 25 minutes | Facility | 2022 | 50 | 56 | $15,176 | $3,173 | 20.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 16 | 16 | $10,250 | $2,699 | 26.3% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 38 | 38 | $10,260 | $2,160 | 21.1% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 25 | 55 | $8,085 | $1,819 | 22.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 242 | 659 | $177,930 | $39,724 | 22.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 132 | 134 | $52,682 | $11,970 | 22.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 49 | 49 | $24,990 | $5,469 | 21.9% |
| 99219 | Hospital observation care, typically 50 minutes | Facility | 2021 | 49 | 49 | $24,696 | $5,454 | 22.1% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 70 | 70 | $18,900 | $4,247 | 22.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 53 | 53 | $14,310 | $3,186 | 22.3% |
| 99225 | Subsequent observation care, typically 25 minutes per day | Facility | 2021 | 46 | 52 | $14,092 | $3,153 | 22.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 15 | 15 | $11,250 | $2,556 | 22.7% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 40 | 68 | $9,996 | $2,179 | 21.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 237 | 589 | $159,030 | $36,151 | 22.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 129 | 130 | $51,350 | $11,807 | 23.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 79 | 79 | $40,290 | $9,121 | 22.6% |
About Dr. Pradeep Singh, M.D
Dr. Pradeep Singh, M.D is a Internal Medicine healthcare provider based in Novato, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/26/2008. The National Provider Identifier (NPI) number assigned to this provider is 1326200726.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Pradeep Singh, M.D has received a total of $390.49 in payments from pharmaceutical and medical device companies, with $17.50 received in 2020. These payments were reported across 25 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($390.49).
As a Medicare-enrolled provider, Singh has provided services to 2,092 Medicare beneficiaries, totaling 4,317 services with total Medicare billing of $326,240. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Hospitalist
- Location Novato, CA
- Active Since 06/26/2008
- Last Updated 09/28/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1326200726
Products in Payments
- TEFLARO (Drug) $90.30
- ELIQUIS (Drug) $81.13
- CHANTIX (Drug) $42.35
- DIFICID (Drug) $36.24
- XARELTO (Drug) $32.33
- ORBACTIV (Drug) $24.42
- MINOCIN IV (Drug) $23.36
- BROVANA (Drug) $18.55
- SAMSCA (Drug) $16.09
- DALVANCE (Drug) $14.40
- BRILINTA (Drug) $11.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Novato
Dr. Michael Kwok, M.d, M.D
Internal Medicine — Payments: $2,743
Barbara Finzen, M.d, M.D
Internal Medicine — Payments: $673.15
Dr. Jason Cataldo, D.o, D.O
Internal Medicine — Payments: $396.27
Dr. Ranjit Hundal, M.d, M.D
Internal Medicine — Payments: $288.99
Teresa Tang, Md, MD
Internal Medicine — Payments: $137.85
Dr. Robert Newbury, Md, MD
Internal Medicine — Payments: $89.81